CXCL8 and neoplasm: a2NTD treatment promotes the mRNA expression of protumorigenic factors correlated with tumor angiogenesis and metastasis; IL-8 (7.98-fold), VEGF (2.2-fold) and MMP-9 (1.87-fold) as compared with PBS-treated neutrophils (Figure 4A).